Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9872309 | International Journal of Radiation Oncology*Biology*Physics | 2005 | 8 Pages |
Abstract
Conclusion: In multivariate analysis, statin use is associated with an improved pCR rate after neoadjuvant chemoradiation for rectal cancer. The low prevalence of statin use limits the power to detect a significant difference at a type I error threshold of p = 0.05 in this analysis. Although no definitive conclusions can be drawn on the basis of this retrospective study, the unusually high incidence of pCR after chemoradiation suggests that the use of statins in the treatment of rectal cancer warrants further evaluation.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Matthew S. M.D., Bruce D. M.D., Leonard B. M.D., Elyn M.A., David B. M.D., Jose G. M.D.,